Relevance of mast cell–nerve interactions in intestinal nociception  by van Diest, Sophie A. et al.
Biochimica et Biophysica Acta 1822 (2012) 74–84
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbadisReview
Relevance of mast cell–nerve interactions in intestinal nociception☆
Sophie A. van Diest a,⁎, Oana I. Stanisor a, Guy E. Boeckxstaens a,b,
Wouter J. de Jonge a, René M. van den Wijngaard a
a Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands
b Division of Gastroenterology, University Hospital Gasthuisberg, Catholic University of Leuven, Leuven, Belgium☆ This article is part of a Special Issue entitled: Mast
⁎ Corresponding author at: Tytgat Institute for Liver
S2-169, Academic Medical Center, Meibergdreef 69-7
Netherlands.
E-mail address: s.a.vanDiest@AMC.UVA.NL (S.A. van
0925-4439/$ – see front matter © 2011 Elsevier B.V. A
doi:10.1016/j.bbadis.2011.03.019a b s t r a c ta r t i c l e i n f oArticle history:
Received 6 February 2011
Received in revised form 11 March 2011
Accepted 30 March 2011
Available online 7 April 2011
Keywords:
Mast cell
Sensory afferent
Neuropeptide
TRP channel
Gut
NociceptionCross-talk between the immune- and nervous-system is considered an important biological process in health
and disease. Because mast cells are often strategically placed between nerves and surrounding (immune)-
cells they may function as important intermediate cells. This review summarizes the current knowledge on
bidirectional interaction between mast cells and nerves and its possible relevance in (inﬂammation-induced)
increased nociception. Our main focus is on mast cell mediators involved in sensitization of TRP channels,
thereby contributing to nociception, as well as neuron-released neuropeptides and their effects on mast cell
activation. Furthermore we discuss mechanisms involved in physical mast cell–nerve interactions. This article
is part of a Special Issue entitled: Mast cells in inﬂammation.cells in inﬂammation.
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It has been long known that the nervous system and the immune
system are able to inﬂuence each other's responses through bidirec-
tional communication [32,56,58,67–69,124,134,141,145,179,180]. The
immune system can inﬂuence nervous system activity through the
release of inﬂammatory mediators and cytokines. In turn, the nervous
system, including the brain and peripheral neurons, can stimulate or
inhibit activities of the innate and adaptive immune response, by acting
on inﬂammatory cells. Mast cells are often found in close proximity to
nerves [13,127,172,173], placing them in a key position to act as the
intermediate cells between the nervous- and immune system. Several
mast cell mediators act on receptors present on sensory afferent nerve
terminals. Receptors present on these afferents, also called nociceptors,
detect and respond to potentially damaging physical and chemical
stimuli (including inﬂammatory mediators), usually resulting in pain
perception. When stimulated, these neurons send signals to the central
nervous system and concomitantly release neuropeptides, such as
substance P and calcitonin-gene related peptide (CGRP). These
neuropeptides can further stimulate mast cell activation creating a
bidirectional positive feedback-loop that may eventually result in
neurogenic inﬂammation [9,110].In this review we will discuss the bidirectional interaction
between mast cells and sensory afferent nerves. Since mast cells
from different tissues are shown to be morphologically, biochemically
and functionally distinct from one another [19], we will restrict this
review and mostly focus on mast cells present in the gastrointestinal
tract. In this setting the mechanism of both mast cell-mediated
activation of sensory afferent neurons resulting in pain perception, as
well as some mechanisms by which neurons can modulate mast cell
function will be discussed. We will conclude with a short summary of
mechanisms discussed in this review and some possible implications
in gastrointestinal diseases like inﬂammatory bowel syndrome (IBD)
and irritable bowel syndrome (IBS).
2. Physical mast cell–nerve interactions
Although close contact between mast cells and neurons has been
well established [13,127,172,173], little is known about the mecha-
nisms involved in their interaction. In in vitro co-culture experiments
nerve cells extended neurites toward rat basophilic leukemia cells
(RBL-2H3), with the majority of RBL cells attached to neurites within
17 h [23]. Using electron microscopy, actual membrane–membrane
contact between mast cells and nerves was shown in vitro [23] and in
vivo [10]. Importantly, degranulation of mast cells in close proximity
to nerves innervating the colonic mucosa, was shown to correlate to
abdominal pain in IBS patients [13]. In the following section, we
discuss methods for cell to cell communication between mast cells
and neurons, as well as adhesion molecules that are relevant for
interaction between both cell types.
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Recently, the cell adhesion molecule 1 (CADM1) was shown to be
intensively expressed at the contact site of both neurites and mast
cells. This molecule is suggested to mediate the adhesion between
both cell types [17,99]. Over-expression of CADM1 was shown to
increase susceptibility of IC-2 cells (a murine cell line with mast cell
progenitor characteristics) to substance P-mediated activation [74].
The authors suggest that homophilic binding between CADM1
expressed on mast cells and neurons, results in either up-regulation
of NK-1 receptors onmast cells or an increase in release of substance P
by neurons, promoting the enhancement of neuron-induced mast cell
activation [74,98,100]. Since substance P is among the factors released
during stress, this could have major implications in stress-induced
exacerbation of disease, such as is seen in IBD and IBS.
Besides CADM1, N-cadherin is expressed by both mast cells and
neurons and is implicated to play a role in the establishment of
membrane–membrane contact in various cell types. In mast cells
N-cadherin is diffusely distributed in the cytoplasm. Association
between a mast cell and neuron causes N-cadherin to trafﬁc to sites of
interaction at the plasma membrane [100,182,216]. Cleavage of
N-cadherin in heterologous cells is mediated by MT5-MMP [130],
which is a matrix metalloprotease expressed in both neuronal and
inﬂammatory cells [12,88,115,146]. In both neurons and mast cells,
deﬁciency in MT5-MMP has been shown to result in abnormal
processing of N-cadherin, with higher levels of full length N-cadherin
at the cell membrane [73]. In monocultures of bone marrow derived
mast cells (BMMC) this abnormal processing did not affect baseline
mast cell degranulation but in mast cell–neuron co-cultures it
resulted in an increased percentage of degranulating cells. In contrast
to wild-type co-cultures, degranulation in mutant co-cultures could
not be further increased by subsequent treatment with nerve growth
factor (NGF) or nociceptor TRPV1 (transient receptor potential)
agonist capsaicin. Since thermal responsiveness after inﬂammation
was diminished in MT5-MMP deﬁcient mice, the authors suggest that
this is due to the inability of mast cells to release mediators required
for ﬁber sensitization. Further investigations suggested that absence
of MT5-MMP results in altered physical contact between mast cells
and sensory ﬁbers [73]. Thus, although more research on this subject
is needed, direct contact between nerves and mast cells, mediated by
adhesion molecules, seems to play an important role under physiolog-
ical and pathological conditions.
2.2. Transgranulation and exosome transfer
In 1983, Greenberg and Burnstock described ‘a novel cell-to-cell
interaction between mast cells and other cell types’, which they
named transgranulation [83]. In co-cultures with ﬁbroblasts the
authors observed formation of specialized mast cell pseudopods that
ﬂattened against the ventral surface of adjacent ﬁbroblasts. These
pseudopods ﬁlled with granules and were eventually cast off and left
on the surface of the adjacent cell. In addition, these investigators
observed granule exocytosis by mast cells and subsequent endocyto-
sis by adjacent ﬁbroblasts. Although not necessarily referring to the
same phenomenon (involving pseudopod formation), Wilhelm et al.
also used the term transgranulation to describe mast cell–nerve
interactions in the medial habenula in the brain of doves [211]. The
habenula region of the brain is, amongmany other functions, involved
in the processing of pain and stress responses [7]. Uptake of mast cell
products by neurons in the brain correlated with mast cells
undergoing piecemeal degranulation (based on granular morphology
and characterized by the presence of variable losses of dense contents
from mast cell granules). Products shown to be captured by neurons
were granule remnants and intragranular particles. The exact role of
this neuronal uptake is not clear but the authors suggested that it may
represent a mechanism to rapidly terminate the stimulus of mast cellsecretary products. However, it has to be taken into account that up to
date, only a few publications concerning this method of communi-
cation exist. Further research needs to be performed to evaluate the
role of such mechanism in mast cell–nerve interactions in the gut.
Another manner of mast cell–nerve communication may occur via
the release of exosomes. Relative to mast cell granules, exosomes are
small vesicles that are secreted from multivesicular bodies upon
fusionwith the plasmamembrane. Because exosomes express speciﬁc
cell surface proteins, including cell adhesion molecules and integrins,
they are able to bind selectively to speciﬁc recipient cells [72,197,203].
Interestingly, investigations performed by Skokos et al. showed that,
within mast cells, exosomes can be localized in mast cell granules
[165]. This suggests that the description of transgranulation by
Wilhelm et al. (neuronal uptake of intragranular mast cell particles)
may also involve neuronal uptake of exosomes. Mast cell-derived
exosomes are implicated in immunomodulation, as they have been
shown to inﬂuence dendritic cell maturation [165] and B- and T-cell
activation [166]. Furthermore, mast cell-derived exosomes transport
functional RNA to recipient cells, suggesting a new pathway for cell
communication [197]. Exosomal signaling has been described in the
central nervous system, where it is suggested that exosomal secretion
of proteins and RNA may be a fundamental mechanism of commu-
nication [167]. To our knowledge, no study was performed to evaluate
exosome-mediated communication between mast cells and neurons
in gut or any other peripheral tissue. It would be interesting, however,
to evaluate if exosomes of both mast cells and peripheral neurons can
bind to and be integrated in one another, and if so, what are the
consequences for cell activation and function.3. Activation of sensory afferent nerves by mast cells
For the gastrointestinal tract, there are 3 main pathways through
which sensory afferent nerves can signal to the central nervous
system; the vagal nerves with cell bodies in the nodose and jugular
ganglia, the splanchnic nerves with cell bodies in the thoracolumbar
dorsal root ganglia (DRG) and the pelvic nerves with cell bodies in the
lumbosacral DRG [22]. In literature, there seems to be a discrepancy in
which one of these pathways is predominantly involved in pain
perception [28,29], which may be explained by differences in time
courses studied. For example, in a mouse model for TNBS (trinitro-
benzene sulfonate) colitis, acute post-inﬂammatory visceral hyper-
sensitivity, present only for 7 days after TNBS treatment, was shown
to predominantly involve splanchnic nerve activation, whereas in
delayed post-inﬂammatory hypersensitivity both splanchnic and
pelvic afferent pathways were involved [93]. Besides differences in
time course, discrepancies may also be explained by differences in
subsets of sensory afferent nerves studied [93].
There are three types of afferent nerve ﬁbers; Aβ ﬁbers, Aδ ﬁbers
and unmyelinated C ﬁbers. Expressing major receptors involved in
pain perception, these C ﬁbers are probably the most important
subtype in mast cell-mediated sensory afferent activation in the
gastrointestinal tract. Based on histological markers, C-ﬁbers can be
further sub-divided into two main groups. In the ﬁrst group neurons
contain binding sites for isolectin B4 (IB4) and are dependent on glial
cell line-derived neurotrophic factor (GDNF). The second group
consists of peptidergic neurons that contain the neuropeptides
calcitonin-gene related peptide (CGRP) and substance P and are
regulated by NGF acting on the TrkA receptor. For the enhanced pain
responsiveness seen after inﬂammation it has been long appreciated
that activation of these NGF-dependent C-ﬁbers exerts a major
contribution [95]. Therefore it is not surprising that these C-ﬁbers
abundantly express nociceptors involved in pain perception, with the
most extensive studied member being the TRPV1 receptor. Several
mast cell mediators are known to modulate nociceptor function [198],
a selection of which will be discussed in this review.
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could directly activate nociceptors, more recent studies suggest that
mast cell-derived compounds sensitize nociceptors by acting on co-
expressed receptors. Probably the best studied intermediate in thismast
cell-mediated sensitization is proteinase activated receptor 2 (PAR2).
Members of the PAR family playan important role in responses to injury,
inﬂammation and repair [61]. As PARs are G-protein coupled receptors,
activation of a PAR itself is not sufﬁcient to induce action potentials in
primary afferent neurons. However, several PARs have been shown to
functionally interact with transient receptor potential (TRP) ion
channels, thereby causing depolarization [5,52,81,163,205]. PAR2 is
the only member of the PAR family that can be activated by mast cell
tryptase [50,97,104,129,137,151,207] and is predominantly expressed
by dorsal root ganglia that co-express TRPV1, TRPV4, TRPA1 (members
of the TRP family) and substance P and CGRP [5,81,175,217]. It is well
established that tryptase-mediated cleavage of sensory afferent-
expressed PAR2 contributes to neurogenic inﬂammation and hyper-
algesia in rodents, partly by stimulating the release of substance P and
CGRP from afferent terminals, causing plasma extravasation, granulo-
cyte inﬁltration and neurogenic inﬂammation in skin and intestine
[42,135,175,206], and partly by sensitizing co-expressed TRP channels
[5,52,81,163].
3.1. TRPV1
The transient receptor potential vanilloid 1 (TRPV1) is a member
of the TRP family of cation-selective channels. TRP receptors may have
various functions, from regulation of blood circulation to pain signal
transduction and hypersensitivity reactions in bladder, airway and
intestine [96]. The relevance of TRPV1 in pain perception has been
validated in studies concerning deletion of the TRPV1 gene
[18,24,36,54,101,153], RNA interference [44] and TRPV1 antagonism
[59,199,213]. In different rat models in which visceral sensitivity is
increased by either TNBS [59] or colonic neonatal irritation [213],
sensitivity to colorectal distensionwas reduced by TRPV1 antagonism.
These results were conﬁrmed in a study using thematernal separation
model for IBS performed in our department [199]. In this model stress
induces a mast cell-dependent increase in sensitivity to colorectal
distension in adult maternally separated rats, which could be
prevented and reversed by treatment with TRPV1 antagonists. In
some animal models, TRPV1 expression is increased and this increase
is thought to contribute to the observed increase in sensitivity [22]. In
the maternal separation model, however, there were no differences in
TRPV1 expression levels between maternally separated rats and non-
handled control rats [199]. In humans, increases in pain perception
are thought to correlate with increases in TRPV1 expressing ﬁbers, as
is shown by Chan et al. who demonstrated that an increase in TRPV1-
expressing ﬁbers in the intestine is associated with increased rectal
sensitivity [43]. Furthermore, in patients with non-erosive reﬂux
disease [16] and IBS [3], TRPV1-expressing ﬁbers may increase up to
3.5 fold in number. In the pathogenesis of both diseases a role for mast
cell activation is implicated.
TRPV1 is abundantly present in the gastrointestinal tract, with
expression on nerves in the mucosa, muscle layer and blood vessels
within the intestinal wall [75,209]. Activation of TRPV1 channels on
trkA+ (NGF-dependent) primary sensory neurons stimulates the
release of substance P and CGRP in peripheral tissues, contributing to
neurogenic inﬂammation. Concomitantly, activation of TRPV1 leads to
cation inﬂux and action potential ﬁring, resulting in pain sensation
[75,184]. TRPV1 can be directly activated by low extracellular pH,
noxious temperature, bioactive lipids and the active component of
chili peppers, capsaicin. In addition, several mast cell mediators have
been shown to modulate TRPV1 functions as will be discussed below.
Interestingly, TRPV1 expression is also shown on human skin mast
cells [169] and mouse BMMCs [20], where activation of TRPV1
channels caused release of IL-4, but not IL-6, TNF-α and serotonin[20]. Since serotonin and histamine are released differentially [189],
the inability of capsaicin to induce serotonin release does not rule out
direct TRPV1-mediated mast cell degranulation. Thus, next to
inhibiting neuronal TRPV1, TRPV1 antagonists may also interfere
with mast cell-expressed TRPV1 and herewith contribute to success-
ful inhibition of pain responses in TRPV1-dependent in vivo models.
This further emphasizes that TRPV1 is an attractive target for pain
suppression in mast cell-dependent pathologies.
Upon mast cell activation several mediators, both pre-formed and
de novo synthesized, can be released. One of the major pre-stored
compounds that is released during mast cell degranulation is
histamine. Interestingly, neurons that are sensitive to histamine
have been shown to mostly overlap neurons that are sensitive to
capsaicin [105], indicating a possible role for histamine in the
activation of TRPV1. Recently it has been shown in vitro that histamine
is able to sensitize TRPV1 functions in mouse DRG [105]. In this study
histamine was shown to enhance intracellular Ca2+ increases and
membrane depolarization in response to acid in both NGF-dependent
and GDNF-dependent sensory neurons. Agonist/antagonist experi-
ments suggested involvement of histamine receptor 1 (HR1) in this
sensitization process through PLC/PKC pathways. Up to date, four
histamine receptors are known; HR1–HR4. Three of these receptors,
HR1, HR3 and HR4, are expressed by dorsal root ganglia [34,136,178]
and activation of these receptors is implicated in pain perception
[49,107,126,142,159]. Although pharmacological intervention of HR3
[126] and HR4 [49] activation caused suppression of pain induced by
chronic constriction injury and carrageenan respectively, HR1 seems
to bemainly implicated in nociceptor sensitization. Also in the TRPV1-
dependent maternal separationmodel for IBS, antagonism of HR1was
able to reverse stress-induced hypersensitivity [170], suggesting that
also in this model histamine acts on HR1 to sensitize TRPV1 channels
and contribute to increased pain perception. Another preformed mast
cell mediator that is implicated to sensitize TRPV1 channels present
on visceral sensory afferent neurons is serotonin (5-HT) [76,133,150].
Receptors for 5HT (5HT1–5HT4) are co-expressed with TRPV1
[192,204] and activation of either the 5-HT2 receptor alone, or both
5-HT2 and 5-HT4 receptors was shown to enhance TRPV1 responses in
rat spinal cord [108] and isolated sensory neurons [140,181]. Recently,
it was shown in vivo that visceral hypersensitivity to colorectal
distension induced by TRPV1 activation is modulated through 5-HT
pathways [150]. However, this study did not determine which 5-HT
receptor was responsible for regulating TRPV1 function.
Intestinal mast cells are considered to be the major source for
tumor necrosis factor-α (TNF-α) in the human body [77]. TNF-α can
be either de novo synthesized or preformed and stored constitutively
within the mast cell granules and is co-released with histamine and
tryptase upon IgE-mediated activation [31,79,193]. Several studies
have shown a correlation between the level of TNF-α expression and
the development of allodynia or hyperalgesia [47,60,122,168]. In vitro,
stimulation of isolated neurons with TNF-α results in elevated
responses to chemical TRPV1-activators [84,92,109,168]. Since rather
long stimulation with TNF-α was needed to induce elevated re-
sponses, these effects are likely due to transcriptional up-regulation of
TRPV1 [92]. In line with this, two research groups show increased
TRPV1 gene expression after TNF-α stimulation in isolated DRG
neurons [89] and in a human synoviocyte cell line [109]. TNF-α acts
through activation of two receptors (TNFR1 and TNFR2) and both can
be detected on sensory neurons [148,162]. However, for TRPV1
sensitization in isolated DRG neurons, TNFR1 seems to be the most
important [89]. Also in a mouse model for pulmonary hypersensitiv-
ity, TNFR1 is implicated in TNF-α-mediated increased responsiveness
of sensory nerve endings to TRPV1 agonists [201].
Two other mast cell mediators capable of modulating TRPV1
functions are NGF and tryptase. NGF is de novo synthesized uponmast
cell activation and is implicated in the up-regulation of TRPV1
expression [6,105,214] and sensitization of TRPV1 channels
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[25,174,219]. It is proposed by Stein et al. that binding of NGF to
trkA facilitates TRPV1 trafﬁcking to the plasma membrane through
physical interaction between trkA, PI3K and TRPV1, thereby increas-
ing TRPV1 function [174]. Sensitization of TRPV1 through activation of
PAR2 by mast cell tryptase requires activation of PKCε and PKA. PAR2
agonists activate PKCε and PKA, causing their translocation from the
cytosol to the plasma membrane, where they may phosphorylate and
thereby sensitize ion channels that participate in nociception [4].
Activation of PAR2 sensitized TRPV1 activity in both mechanical
allodynia and thermal hyperalgesia. However, in this study, where
increases in Fos-expression in the spinal cord were used as a marker
for secondary spinal neuron activation, pain responses and Fos
expression were not completely prevented in TRPV1-knockout mice,
suggesting the involvement of other mechanisms down-stream of
PAR2 activation [52]. Interestingly, in a following study, these authors
demonstrate that interaction between PAR2 and TRPA1, in addition to
TRPV1, might be an important mechanism underlying PAR2-mediated
inﬂammatory pain [138].
3.2. TRPV4
Another member of the vanilloid subfamily, TRPV4, can also be
implicated in mast cell-induced pain perception. Different studies
have deﬁned a role for TRPV4 in the transduction of somatic pain
[70,71,183] and, recently, TRPV4 has been shown to play a major role
in colonic visceral nociception [40,163]. In this study, intracolonic
administration of a synthetic TRPV4 agonist caused a dose-depen-
dent increase in visceral sensitivity to colorectal distension. TRPV4 is
expressed by the majority of primary spinal afferent neurons
innervating the colon, with a high expression on both pelvic and
splanchnic DRG [30]. Consistent with this expression pattern,
deletion of the TRPV4 gene increased both pelvic and splanchnic
thresholds for mechanosensation, while vagal afferent functions did
not change [218]. In the periphery, TRPV4 is expressed on NGF-
dependent neurons that contain substance P and CGRP and activation
causes neuropeptide release and Ca2+ mobilization and subsequent
action potential ﬁring [81]. Both histamine and 5-HT have been
shown to sensitize responses of TRPV4 in vivo and in vitro [41].
Pre-treatment of isolated sensory neurons with either histamine or
5-HT enhanced Ca2+ signals in response to a TRPV4 agonist.
Expression levels of TRPV4 at the plasma membrane were increased
after treatment with histamine or 5-HT, concomitantly with a
decreased expression in the nuclear and perinuclear compartment.
Furthermore, histamine and 5-HT not only enhanced the amplitude
of the response to the agonist, but also increased the number of
responding neurons. The authors show that histamine-induced
sensitization of TRPV4 is partially mediated by HR1, while 5-HT-
induced sensitivity is mediated by the 5-HT3 receptor. Intracolonic
administration of histamine or 5-HT caused visceral allodynia and
hyperalgesia to colorectal distension in mice. This hypersensitivity
did not develop when mice were intrathecally injected with TRPV4
siRNA. Interestingly allodynia in response to histamine did not
depend on TRPV4 expression.
3.3. TRPA1
The ankyrin subfamily of the TRP family of receptors contains
only one member; TRPA1. TRPA1 is the mammalian orthologue of
the Drosophila gene painless and studies using TRPA1 knockout
mice, antisense knock-down of TRPA1 and pharmacological
inhibition of TRPA1 demonstrate a signiﬁcant role for TRPA1 in the
processing of nociceptive information in inﬂammatory- and nerve
injurymodels [14,112,125,138,147]. TRPA1mediates cold, mechanical
and chemical nociception and can be activated by temperatures under
17 °C [177], extracts of mustard, cinnamon, oregano and garlic[11,15,48,102,177,215], as well as a wide range of environmental
irritants [14,120,125]. TRPA1 is localized on GDNF-dependent sensory
nerves of all three pathways innervating the intestine; vagal,
splanchnic and pelvic afferents [22] and is extensively co-expressed
with TRPV1 [11,62,102,138,176]. Both TRPV1 and TRPA1 can be
activated by intracellular [63,200] and extracellular Ca2+ [1,39].
Activation by extracellular Ca2+ results in a baseline supply of Ca2+
into the cell, which may maintain Ca2+-dependent processes, such as
transcription regulation and phosphorylation. Activation by intracel-
lular calcium may account for mechanisms of TRPA1 gating by
inﬂammatory mediators [11,220]. Interestingly, activation of TRPA1
by both intracellular and extracellular Ca2+ is shown to be controlled
by the TRPV1 channel [143], demonstrating functional interaction
between both channels. Being a rather newmember of the TRP family
of receptors, not much is yet examined about the mechanisms of mast
cell-mediated activation or sensitization of TRPA1. However, some
studies provide evidence for PAR2-mediated sensitization of TRPA1
channels. TRPA1 is highly co-localized with PAR2 in rat DRG neurons
and functional interaction depending on activation of PLC was shown
in both TRPA1-transfected HEK293 cells as well as in DRG neurons
[53]. Interaction between PAR2 and TRPA1 is also shown in the guinea
pig gastrointestinal tract, where mast cell-induced activation of PAR2
was shown to contribute to mechanical hypersensitivity of esopha-
geal vagal nerves, through sensitization of TRPA1 [217]. In this study,
however, possible involvements of TRPV1 and TRPV4 were not
excluded.
3.4. MRG receptors
Mas-related G-protein-coupled (Mrg) receptors, ﬁrst described in
2001, are predominantly, but not exclusively, expressed by IB4+
(GDNF dependent) sensory neurons [87]. Because of their selective
expression on sensory nerves, Mrg receptors are also called sensory
neuron speciﬁc receptors (SNSR) [114] and are implicated to play a
role in nociception. In human, seven Mrg receptors are expressed;
MrgX1-MrgX7, while in rodents, the family of Mrg receptors can be
further subdivided in MrgD and three subfamilies; MrgA, MrgB and
MrgC based on homology analysis [113]. Several ligands such as; BAM
peptides, neuropeptide FF (NPFF), dynorphin 14 and γ2-melanocyte-
stimulating hormone are capable of activating Mrg-receptors
[64,87,90,106,114,116,131,132,139,152,186,221]. Peptides known to
activate the MrgC receptor have been shown to elicit pain-like
behavior when administrated to rats [82]. Furthermore deletion of
both MrgD [38] as well as MrgE [51] in mice was shown to affect
mechanosensation and the development of allodynia respectively.
Interestingly, approximately half of the Mrg-expressing neurons
(both IB4+ as well as TrkA+) co-expressed TRPV1, suggesting a
possible interaction between both receptors [114]. Indeed MrgC
agonist BAM22 (bovine adrenal medulla peptide 22) was shown
to facilitate CGRP release induced by TRPV1 agonist capsaicin.
However, both deletion of the TRPV1 gene as well as antagonizing
its activation with caspazepine had no effect on BAM22-induced CGRP
release [85]. Therefore, to draw any ﬁrm conclusions on the possible
interaction between Mrg receptors and TRP channels, more reseach is
needed.
Interestingly, IgE-dependent activation of both mouse BMMC and
RBL cells was shown to induce release of mediators capable of
activating MrgC [113]. The authors suggest that, RF-amides, such as
NPFF, released by mast cells may be responsible for activation of
sensory neuron-expressed MrgC. Importantly, Mrg receptor expres-
sion was also found on human peripheral blood-derived connective
tissue-typemast cells (MrgX1 andMrgX2 expression) aswell as on rat
peritoneal mast cells (MrgB expression). In both cell types, activation
of the Mrg receptor (by several Mrg ligands) resulted in a dose-
dependent increase inmast cell degranulation [186]. Therefore, in vivo
effects on pain perception induced by ligand-mediated activation of
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involvemast cell activation and subsequent stimulation of nociceptive
neurons by mast cell mediators.
4. Activation of mast cells by sensory afferent nerves
Among the earliest evidence for the involvement of neuronal
mechanisms inmast cell activation is a study performed byMacQueen
et al. [121]. In this study antigen injections were paired with an
audiovisual cue in rats. Re-exposure to only the audiovisual cue
caused a RMCP2 (rat mast cell protease 2) release that was similar to
the release of RMCP2 in rats that were re-exposed to both the
audiovisual cue and the antigen, as is seen in Pavlovian conditioning.
Since then an overwhelming amount of evidence was published to
indicate that neuronal activation can modulate mast cell function and
thereby affect and regulate the immune system and its response
under inﬂammatory conditions [212]. Here we discuss several of the
neuropeptides released from afferent nerve endings which were
shown to cause mast cell mediator release and functional alterations
in mast cell receptor proﬁle.
4.1. Modulation of mast cell function by neuropeptides
As mentioned earlier in this review, neurons can release
mediators, such as neuropeptides, upon activation. Several of these
mediators (such as substance P, CGRP, vasoactive intestinal protein
(VIP), dopamine, arachidonic acid) are able to inﬂuence mast cell
activation, a selection of which is discussed in this review.
Substance P is probably the most extensively studied neuropeptide
in relation to mast cell activation. However, there seems to be a
discrepancy whether intestinal mast cells express neurokinin (NK)
receptors for substance P. Kulka et al. show protein expression of NK-1,
NK-2 and NK-3 in LAD2 cells and NK-1 in CD34+-derived mast cells,
which was up-regulated after antigen stimulation [111]. In contrast,
Bischoff et al. were unable to detect any NK-1 expression in isolated
human intestinal mast cells [21], suggesting that mast cell susceptibility
to substance P may depend on the local environment. Despite this,
Shanahan et al. showed that high doses of substance P induce histamine
release in mucosal mast cells [158]. Because of the high dosage needed
these data may indicate that SP-induced histamine release by mucosal
mast cells is irrelevant, but they simultaneously show that functional
NK-receptors may be present. The latter is important because
nanomolar concentrations of substance P were shown to induce TNF-
α release without release of histamine or other mediators [8].
Importantly, in addition to mediator release, substance P has been
shown to inﬂuencemast cell function by up-regulation of TLR receptors
[185]. Substance P was shown to increase expression levels of TLR2,
TLR4 andTLR8 in the LAD2humanmast cell line. It primed these cells for
subsequent TLR2-agonist stimulation [185] and was shown to down-
regulate the expression of the high afﬁnity IgE receptor [123]. These
changes in receptor proﬁle render the mast cell more susceptible for
direct activation by bacterial antigens instead of indirect activation
through anti-bacterial IgE, whichmayhavemajor implications in various
diseases.
Substance P and CGRP are not only considered as major initiators
of neurogenic inﬂammation [91,195,202] but CGRP is also implicated
to play a role in (mast cell-dependent) epithelial cell migration during
wound healing [33]. Despite this, there are not much data available on
the effects that CGRP may exert on mucosal mast cells. In a recent
study however, CGRP stimulation induced release of relatively small
amounts of mMCP-1 without degranulation, which was not depen-
dent on extracellular Ca2+, indicating piecemeal degranulation
[65,66,191]. In this study subunits of the CGRP1 receptor were
expressed on the majority of BMMCs [149], which are thought to
resemble mucosal mast cell morphology and mediator content
[119,128]. The observed role of piecemeal degranulation may behighly relevant. Not only has it been shown to be involved in the
release of other mast cell mediators, but this mechanism of mast cell
activation is also implicated in activation of mast cells in close
proximity to nerves [149].
Besides CGRP, vasoactive intestinal protein (VIP) has also been
shown to induce piecemeal degranulation in mast cells [196]. VIP is a
prominent neuropeptide, produced by nerves in the central and
peripheral nervous system, with functions ranging from neurotrans-
mission to immunomodulation [154,155]. Mast cells have also been
shown to express a truncated form of VIP but the function of this
peptide is unclear [78,111,210]. Expression of VIP receptor type 2
(VPAC2) but not VPAC1 has been shown on human mast cells (LAD
and primary cultured mast cells) [111]. IgE crosslinking increased
VPAC2 expression and rendered cells more susceptible to VIP-induced
degranulation of β-hexosaminidase. VIP also induced signiﬁcant
production of chemokines and cytokines like MCP-1, RANTES, Il-
8 and TNF-α and Il-3. Interestingly, mast cell-derived tryptase is able
to cleave VIP, while chymase was shown to degrade both VIP and
substance P [37], indicating a balancing reaction of mast cells to
afferent nerve-induced activation.4.2. Cholinergic modulation of mast cells
A close anatomic relation between vagal nerve endings and
intestinal mucosal mast cells has been shown [172] and depletion of
the vagal nerve resulted in approximately 25% fewer mast cells in the
jejunal mucosa than in sham operated controls [80]. Based on the
trophic effects vagal nerves can exert on stomachmucosa [80,86], this
observation leads to the suggestion that the vagal nerve exerts trophic
effects on mast cells. The vagus nerve, via release of its principal
neurotransmitter acetylcholine, is also involved in the control of
immune responses. Activation of the so called ‘cholinergic anti-
inﬂammatory pathway’ by electrical stimulation of the vagus nerve or
nicotinic acetyl choline (nACh) agonists ameliorates inﬂammation
and improves survival in various experimental models for sepsis and
inﬂammation [26,27,144,188,208]. These effects are mediated by
nACh receptors expressed on inﬂammatory cells. Mouse BMMCs
express mRNA for α4, α7 and β2 nACh receptor subunits and nACh
receptor agonists were shown to inhibit IgE-induced degranulation of
mucosal mast cells [103]. It has to be taken into account that
signiﬁcance was only achieved at relatively high concentrations
(≥3.2mM) of nicotine, compared to the concentration of nicotine
found in plasma of smokers (100 nM) [94]. The authors state that
differences in sensitivity for nicotine may exist between different
mast cell subtypes. In line with their observation, also in basophiles
millimolar concentrations of nicotine were needed to inhibit IgE-
mediated histamine release [194]. In vivo, vagal stimulation caused an
increase in histamine-immunoreactivity in intestinal mucosal
mast cells [171]. Whether this involves increased histamine synthesis
or a decrease in release remains to be established. Taking into account
the inhibitory effect of nicotine treatment on histamine release in
vitro, the latter seems most probable. Further evidence that vagal
stimulation inﬂuences mast cell degranulation was obtained in a
model for postoperative ileus which is a (mast cell-dependent
[57,187]) post-operative complication that results from manipulation
of the bowel during abdominal surgery. The cholinergic anti-
inﬂammatory pathway can be physiologically activated by adminis-
tration of lipid-rich nutrition, through activation of CCK-receptors
[118]. When post-operative ileus was induced in rats, administration
of lipid-rich nutrition reduced release of RMCP-II, indicating that
a high fat diet can prevent manipulation-induced mast cell
degranulation [117]. Recently, also in a rodent shock model high-
lipid nutrition was shown to modulate mast cell activation [55],
providing strong evidence for inhibitory effects of vagal nerve
activation on mast cells.
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Corticotropin releasing factor (CRH) has a major function in
regulating the stress response by activation of the hypothalamic–
pituitary–adrenal (HPA) axis and the sympathetic nervous system
[45]. In addition, CRH was shown to induce degranulation of
peripheral mast cells upon acute stress in rodent models. The exact
source of mast cell-activating CRH is unknown, however, CRH has
been shown to co-localize with substance P in capsaicin-sensitive
neurons [164]. Release of CRH from activated neuronal terminals
could provide a pro-inﬂammatory pathway for mast cell degranula-
tion or mediator release during stress. Importantly, human umbilical
cord-derived mast cells have also been shown to functionally express
subunits of both types of CRH receptors; CRHR1 and CRHR2. In the
human mast cell line, HMC-1, expression of only CRHR1 subunits was
found [35] but it has to be noted that HMC-1 cells are considered
immature mast cells and may not represent mast cells in situ. CRH-
induced activation of umbilical cord-derived mast cells as well as
HMC-1 cells caused selective secretion of vascular endothelial growth
factor (VEGF), without secretion of tryptase, histamine, IL-6, IL-8 or
TNF-α [35]. This differential release of VEGF may represent piecemeal
degranulation [190] but at present no clear evidence exists that VEGF
is among the mediators that can be released by this type of
degranulation: granule density and other features of piecemeal
degranulation were not determined after CRH-induced VEGF release.
Thus, further investigations are needed, especially because Santos et
al. showed that piecemeal degranulation may indeed be important in
stress-induced mast cell activation [157]. Although most of the
published stress/gut mast cell investigations concern models for IBS,
signs for piecemeal degranulation have also been found in mucosal
mast cells in the gastrointestinal tract of patients with IBD [66]. In IBD,
stress-induced exacerbations of symptoms and relapse of disease areFig. 1. Mast cell mediators such as serotonin, tryptase and histamine interact with their s
coupled receptor pathways, induce TRP-channel sensitization. The lowered threshold for act
which in turn drives the release of pre-stored neuropeptides such as CGRP, CRH, VIP and
neuropeptide release to further induce mast cell activation/degranulation as well as other p
Next to direct mast cell mediator-induced afferent activation there is convincing evidence of
cell-derived exosomes. It is not clear at present what the relevance of this phenomenon is.prominent and these observations indicate that neuron–mast cell
interactions may play an important role.
5. Bidirectional mast cell–nerve interactions: summary and
implications in intestinal disease
In this review we focused on the mechanisms for bidirectional
interaction between mast cells and sensory afferent nerves, summa-
rized in Fig. 1. As is shown in this ﬁgure, several mast cell mediators
can sensitize nociceptors through activation of receptors that are co-
expressed by sensory afferent neurons and thereby reduce the
threshold for activation of these nociceptors. Activation of these
afferents stimulates release of neuropeptides, several of which can
change the mast cell receptor proﬁle, modulate mast cell function or
stimulate mast cell mediator release, herewith creating a positive
feedback loop for ongoing mast cell activation and nociceptor
sensitization. This mechanism is considered relevant for pathologies
in which mast cells and changes in sensitivity are involved.
Stress can cause neuropeptide release (e.g. substance P and CRH)
from peripheral nerve terminals. As discussed in this review, these
neuropeptides can induce release of mast cell mediators either by
piecemeal- or classic degranulation. Furthermore, substance P is
shown to induce changes in mast cell mediator proﬁle, making the
mast cell more susceptible for direct activation by bacterial antigens.
The latter could have major implications not only in IBS pathology, in
which intestinal barrier dysfunction is implicated, facilitating the
passage of bacteria through the lumen, but also in pathologies with
stress-induced exacerbations of symptoms, like IBD. In both IBS and
IBD, expression of TRPV1 is implicated to play a role in increased pain
perception. In IBS patients mast cell activation in close proximity to
nerves [13] and the amount of TRPV1 expressing ﬁbers [3] are shown
to correlate with abdominal pain. To our knowledge, in literaturepeciﬁc (sensory afferent expressed-) receptors which then, through phospholipase C-
ivation can result in TRP-channel activation, membrane depolarization and Ca2+ inﬂux
substance P. Propagated action potentials can lead to increased pain perception and
henotypical changes in these cells (i.e. lowered FcεR1- and increased TLR-expression).
neuronal uptake of mast cell granules (complete as well as remnants) and perhaps mast
80 S.A. van Diest et al. / Biochimica et Biophysica Acta 1822 (2012) 74–84there is no evidence for up-regulation of both TRPV4 and TRPA1
expression in IBSpatients.However, increasedmRNAexpressionof both
HR1 and HR2 was shown in biopsy material of IBS patients [156],
suggesting that these receptorsmight be involved in the sensitization of
TRPV1 channels in these patients. In IBD patients, activation of TRPV1
channels is implicated in increased pain sensation. In patients with
quiescent IBD but with abdominal pain, TRPV1-expressing ﬁbers were
increased up to 5 fold when compared to quiescent IBD without
abdominal pain [2]. The latter data suggest that nociceptors like TRPV1
can be a pharmaceutical target in IBS as well as IBD patient-subsets.
In conclusion, and although we are only on the verge of
understanding the exact pathways involved in mast cell-nerve
communication, it seems clear that these bidirectional interactions
form a major contribution to gut disorders like IBS and IBD. Thus,
furthering our knowledge on these interactions may lead to new
treatment opportunities.
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